Hologic Inc. (HOLX), a maker of cervical cancer and breast biopsy tools, adopted a shareholder’s rights plan after billionaire investor Carl Icahn reported a stake in the company. Hologic surged in early trading. The rights plan is designed to make sure all shareholders are “appropriately compensated” and the board has time to make “informed judgements” in case a person or group tries to gain control of the company, Bedford, Massachusetts-based Hologic said in a statement today. Icahn said in a separate regulatory filing today that he may seek representation on Hologic’s board.
Help employers find you! Check out all the jobs and post your resume.
